FR940816-0-00006 FR940816-0-00004 21 CFR Parts 510 and 522 Animal Drugs, Feeds, and Related Products; Ketamine Hydrochloride Injection, USP AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by American Veterinary Products, Inc. The ANADA provides for intramuscular use of ketamine hydrochloride injection in cats for restraint, or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation, and in subhuman primates for restraint. EFFECTIVE DATE: August 16, 1994. FOR FURTHER INFORMATION CONTACT: Charles W. Francis, Center For Veterinary Medicine (HFV&hyph;114), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1617. SUPPLEMENTARY INFORMATION: American Veterinary Products, Inc., 749 South Lemay, suite A3&hyph;231, Fort Collins, CO 80524, filed ANADA 200&hyph;073 which provides for intramuscular use of Ketamine Hydrochloride Injection, USP, in cats for restraint, or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation, and in subhuman primates for restraint. The drug is limited to use by or on the order of a licensed veterinarian. American Veterinary Products' ANADA 200&hyph;073 for Ketamine Hydrochloride Injection, USP, is approved as a generic copy of Fort Dodge's NADA 045&hyph;290 for Vetalar ® / Ketaset ® (ketamine hydrochloride injection, USP). The ANADA is approved as of July 21, 1994, and the regulations are amended by revising 21 CFR 522.1222a(c)(1) to reflect the approval. The basis of approval is discussed in the freedom of information summary. In addition, American Veterinary Products, Inc., has not previously been listed in 21 CFR 510.600(c)(1) and (c)(2) as sponsor of an approved application. That section is amended to add entries for the firm. In accordance with the freedom of information provisions of part 20 (21 CFR part 20) and §514.11(e)(2)(ii) (21 CFR 514.11(e)(2)(ii)), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20855, between 9 a.m. to 4 p.m., Monday through Friday. The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the action will not have a significant impact on the human environment and that an environmental impact statement is not required. The agency's finding of no significant impact and the evidence supporting that finding, contained in an environmental assessment, may be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday through Friday. List of Subjects 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. 21 CFR Part 522 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 522 are amended as follows: PART 510_NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e). 2. Section 510.600 is amended in the table in paragraph (c)(1) by adding alphabetically a new entry for American Vetrinary Products, Inc., and in the table in paragraph (c)(2) by adding numerically a new entry for ``045984'' to read as follows: §510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. * * * * * (c) *␣*␣* (1) *␣*␣* 1Firm name and address 1Drug labeler code ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ American Veterinary Products, Inc., 749 South Lemay, Suite A3&hyph;231, Fort Collins, CO 80524 045984 ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ (2) *␣ *␣ * 1Drug labeler code 1Firm name and address ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ 045984 American Veterinary Products, Inc., 749 South Lemay, Suite A3&hyph;231, Fort Collins, CO 80524. ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 522 continues to read as follows: Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). 2. Section 522.1222a is amended by revising paragraph (c) to read as follows: §522.1222a Ketamine hydrochloride injection. *␣ *␣ *␣ *␣ * (c) Sponsors. (1) See Nos. 000856, 057319, and 045984 in §510.600(c) of this chapter. *␣ *␣ *␣ *␣ * Dated: August 8, 1994. Richard H. Teske, Deputy Director, Premarket Review, Center for Veterinary Medicine. [FR Doc. 94&hyph;20066 Filed 8&hyph;15&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
